{
    "2021-12-07": [
        [
            {
                "time": "2020-01-01",
                "original_text": "公司主打产品甘精胰岛素注射液，在2020年先后中标白俄罗斯市场、顺利出口至土耳其、黎巴嫩、尼日尔等新兴国家，并获准在哈萨克斯坦上市销售",
                "features": {
                    "keywords": [
                        "甘精胰岛素",
                        "出口",
                        "新兴国家",
                        "中标",
                        "哈萨克斯坦"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-06-01",
                "original_text": "甘李药业的精蛋白人胰岛素混合注射液（30R）在2021年年中取得注册批件，尚未形成大规模销售",
                "features": {
                    "keywords": [
                        "精蛋白人胰岛素",
                        "注册批件",
                        "大规模销售"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-01",
                "original_text": "甘精胰岛素（GL-GLA）已成功完成两项海外随机、多中心、III期研究",
                "features": {
                    "keywords": [
                        "甘精胰岛素",
                        "海外研究",
                        "III期"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "甘李药业副总经理、美国子公司CEO Lawrence Hill的辞职不会对公司日常的生产经营带来实质性影响",
                "features": {
                    "keywords": [
                        "辞职",
                        "美国子公司",
                        "生产经营"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "公司所有组别均有品种中选 A 类，在获得基础量之外还可获得 C 类调出的分配量，有利于市场份额进一步提升",
                "features": {
                    "keywords": [
                        "市场份额",
                        "A类",
                        "C类",
                        "分配量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "山东临沂新建厂项目的建设按照计划顺利进行中",
                "features": {
                    "keywords": [
                        "新建厂",
                        "临沂",
                        "计划"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "公司生产经营稳定向好，不存在资金打压公司股价的情况",
                "features": {
                    "keywords": [
                        "生产经营",
                        "稳定向好",
                        "资金打压"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-01",
                "original_text": "甘李药业一糖尿病在研药物获FDA临床试验批准",
                "features": {
                    "keywords": [
                        "糖尿病",
                        "FDA",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-12-15",
                "original_text": "关于公司2021年股票期权激励计划 股票期权首次授予登记完成的公告",
                "features": {
                    "keywords": [
                        "股票期权",
                        "激励计划",
                        "首次授予"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}